This new Venture plans to fight Multiple Sclerosis through ‘NanoMedicine’, which is supported by Cambridge Judge Business School.

The grant itself has been funded £1 million new funding to explore this dieases area. Of the £1 million funding receieved more than £828,000 will be through the government’s Innovate UK BioMedical Catalyst Competition awarded to LIFNanoRx – which has brought together a project team that includes Pharmidex; the University of London’s Blizard Institute – a world-renowned center for treatment of MS; and the Government’s Center for Process Innovation. 



You can find more information on the following website: http://www.epe.admin.cam.ac.uk/grant-lifnanorx